These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8297526)

  • 21. [Biological therapy in rheumatoid arthritis].
    Abraham Simón J
    Rev Invest Clin; 2001; 53(5):452-9. PubMed ID: 11795111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen specific therapies for the treatment of autoimmune diseases.
    Hafler DA; Weiner HL
    Agents Actions Suppl; 1995; 47():59-77. PubMed ID: 7785504
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential.
    Shoenfeld Y; Toubi E
    Arthritis Rheum; 2005 Sep; 52(9):2599-606. PubMed ID: 16142758
    [No Abstract]   [Full Text] [Related]  

  • 26. Unravelling autoimmune pathogenesis by screening random peptide libraries with human sera.
    Fierabracci A
    Immunol Lett; 2009 May; 124(1):35-43. PubMed ID: 19375456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 29. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapeutic approaches with monoclonal antibodies to immunological diseases.
    Cozzi E; Ferrone S
    Recenti Prog Med; 1992 Sep; 83(9):528-33. PubMed ID: 1439123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines to prevent and treat autoimmune diseases.
    Mor F; Cohen IR
    Int Arch Allergy Immunol; 1995 Dec; 108(4):345-9. PubMed ID: 7580306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock proteins in autoimmune disease. From causative antigen to specific therapy?
    Yang XD; Feige U
    Experientia; 1992 Jul; 48(7):650-6. PubMed ID: 1639173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-gamma interferon (IFN-gamma) monoclonal antibodies.
    Bach JF
    Immunol Ser; 1993; 59():319-28. PubMed ID: 8461396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference].
    Waldmann TA
    JAMA; 1990 Jan; 263(2):272-4. PubMed ID: 2294293
    [No Abstract]   [Full Text] [Related]  

  • 37. Rituximab in autoimmune cytopenias: for which patients?
    Finazzi G
    Haematologica; 2002 Feb; 87(2):113-4. PubMed ID: 11836158
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune therapy for autoimmune diseases.
    Steinman L
    Science; 2004 Jul; 305(5681):212-6. PubMed ID: 15247472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
    Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
    Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.